WT cells exhibit retarded growth and higher ROS levels after BCM treatment. by Anand Prakash (1846540)

“…<b>B</b>. Higher levels of superoxide were detected after BCM treatment with DHE in WT. *, <i>P</i> < 0.05. …”

Resolution of tracing tasks by the hub for 2wT participants during campaign periods vs. routine VMMC levels, South Africa, 2023. by Molly Unsworth (21161686)

Plasma levels of PCSK9 in ASGR1-deficient pigs and WT controls. by Baocai Xie (7889621)

Functional validation of WT and mutant CDT. by Kateryna Nabukhotna (19704632)

MESO-4 pre-treated with ONX-0914 showed an increase in sensitivity to cytotoxic T cells. by Masaki Ito (342933)

Showing area measurements of ascorbate level (at approximately 6 min.) in WT and nine mutants. by Asaad M. Mahmood (9745690)

Seeds undergoing controlled deterioration treatment (CDT) increase PA levels and enhance phyA-mediated seed germination. by Woohyun Kim (1234284)

NHERF1 protein levels increase with increased cell density. by Camille M. Drews (4721175)

“…As confluency increased, NHERF1 protein levels also increased, though still reduced in the presence of 16E6_WT. …”

Nephrectomy of WT with or without PBS exposure upregulates osteoblast-related gene expression in femurs. by Sasithorn Wanna-udom (12666977)

Nephrectomy in WT with or without PBS exposure upregulates osteoclast-related gene expression in femurs. by Sasithorn Wanna-udom (12666977)

Increase in cAMP at the plasma membrane evoked by simultaneous inhibition of PDE3 and PDE4 only in WT and AC5KO. by Caroline Bull Melsom (627676)

Discovery of Selective Dopamine Receptor Ligands Derived from (−)-Stepholidine via C‑3 Alkoxylation and C‑3/C‑9 Dialkoxylation by Hari K. Namballa (13363787)

Subjects:

Discovery of Selective Dopamine Receptor Ligands Derived from (−)-Stepholidine via C‑3 Alkoxylation and C‑3/C‑9 Dialkoxylation by Hari K. Namballa (13363787)

Subjects:

One-dimensional simulations for WT and all homozygous mutations. by Yirong Xiang (17624534)

Temporal vulnerability windows for WT and all homozygous mutations. by Yirong Xiang (17624534)

Two-dimensional simulations for WT and all homozygous mutations. by Yirong Xiang (17624534)

rHsGal-1 does not affect WT levels of ANXA1/6. by Mary L. Vallecillo-Zúniga (9338678)

PilB T430X constructs complement twitching motility to at least WT levels. by Nathan Roberge (11605723)

Cardiac signaling via ERK1/2 was increased in untreated PAR2 deficient mice. by Albrecht Meyer zu Schwabedissen (20390671)

Subjects:

Ventricular arteriolar wall thickness was increased in PAR2 deficient mice treated with AngII. by Albrecht Meyer zu Schwabedissen (20390671)

Subjects: